Population Bio Inc - Company Review
SummaryPopulation Bio Inc - Company Review
Summary
Population Bio Inc (PB), formerly Population Bio Inc is a biotechnology company that develops DNA-based diagnostics and personalized medicine tests. The company performs research, development and discovery of platform technology for validation of causative genetic biomarkers. Its RationalCNV analysis provides medical relevance to variants of unknown significance and novel variants. PB develops various therapies such as novel targeted drugs, drug rescue of Phase II & III failures, repositioning or repurposing of FDA-approved drugs. The company offers products for various diseases such as autism spectrum disorder, endometriosis, parkinson's disease, peanut allergy and alzheimer's disease. It has its operational presence in the UK. PB is headquartered in Melville, New York, the US.
This comprehensive company report of Population Bio Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.